HIV-1 matrix protein p17 induces human plasmacytoid dendritic cells to acquire a migratory immature cell phenotype.
about
Blocking TLR7- and TLR9-mediated IFN-α production by plasmacytoid dendritic cells does not diminish immune activation in early SIV infectionThe HIV matrix protein p17 subverts nuclear receptors expression and induces a STAT1-dependent proinflammatory phenotype in monocytesMajor depletion of plasmacytoid dendritic cells in HIV-2 infection, an attenuated form of HIV diseaseSimian immunodeficiency virus and human immunodeficiency virus type 1 matrix proteins specify different capabilities to modulate B cell growth.Plasmacytoid dendritic cells in HIV infection: striking a delicate balance.Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells.HIV-1 p17 matrix protein interacts with heparan sulfate side chain of CD44v3, syndecan-2, and syndecan-4 proteoglycans expressed on human activated CD4+ T cells affecting tumor necrosis factor alpha and interleukin 2 production.HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2.Angiogenic, lymphangiogenic and adipogenic effects of HIV-1 matrix protein p17.Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance.Molecular interaction studies of HIV-1 matrix protein p17 and heparin: identification of the heparin-binding motif of p17 as a target for the development of multitarget antagonistsCoxiella burnetii Induces Inflammatory Interferon-Like Signature in Plasmacytoid Dendritic Cells: A New Feature of Immune Response in Q Fever.HIV interactions with monocytes and dendritic cells: viral latency and reservoirs.Expression of HIV-1 matrix protein p17 and association with B-cell lymphoma in HIV-1 transgenic mice.New developments in lentiviral vector design, production and purification.Effect of type-I interferon on retroviruses.A single amino acid substitution confers B-cell clonogenic activity to the HIV-1 matrix protein p17.Role of Autophagy in HIV-1 Matrix Protein p17-Driven Lymphangiogenesis.A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: implications for EBV-driven lymphomagenesis in the HIV setting.HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disorders.Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17.Long-lasting humoral immune response induced in HIV-1-infected patients by a synthetic peptide (AT20) derived from the HIV-1 matrix protein p17 functional epitope.The HIV matrix protein p17 induces hepatic lipid accumulation via modulation of nuclear receptor transcriptoma.HIV-1 matrix protein p17 and its variants promote human triple negative breast cancer cell aggressiveness.
P2860
Q27334176-82021B44-5EAD-430D-AA03-D260B1AC493BQ28730200-786F3C94-A4BD-435E-A065-C745027716ACQ30912292-C8B4FADF-AA69-4D08-9119-14A553DD93C9Q33602706-465BADD9-E9B4-4BBB-B757-461733B68BEEQ33805319-1B2C4413-B1D1-4931-883F-89E7459BEC39Q33851786-B134D36A-ECFD-4727-B548-28F37DFCFF5EQ35010983-4B79E1FC-5317-493B-878D-18E04BCCC6B6Q36221840-4E7E23EE-8C5F-44FC-8026-24A7643DAC8DQ36226553-E7768857-43A9-4896-9E92-F2986FFAFDBFQ36426325-619326DE-34A8-4712-BB9F-31707A43C029Q36526260-1AC231E9-64B0-4E77-B25A-132A1FE4A89EQ37039087-09D4C773-F2D8-445D-80F6-F1FE9FC33E2FQ37229398-434309F0-2483-4A04-B872-18D65F2454AEQ37469500-F0B84217-0D10-424D-B4F6-D8A8E49B5EF6Q38099382-9579D3EF-7906-40F6-A560-6ACDE3511FF5Q38613681-358E9A47-BBE2-433D-95AF-44AD881A97D4Q38659232-EB3F6BC2-B636-49DF-A5BC-F20C9C6CF5E0Q38673536-D9676C2E-CE48-4B14-9171-AC82F93C684DQ38907078-B7E0307C-5958-46F0-A32D-FC7B8E379482Q40058240-99E371DD-F094-4EDB-ABDB-116D56954C7BQ40428203-C5ADD6B0-076A-4605-AEA4-A298B472E6FDQ40854172-9FE6EF47-19A5-49FE-8938-DFF2B7576872Q40951514-A49A6E05-D573-43A1-82C0-24DC7FF825D1Q41918626-1FC539A5-D136-4CED-8AF3-6B339851B92E
P2860
HIV-1 matrix protein p17 induces human plasmacytoid dendritic cells to acquire a migratory immature cell phenotype.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
HIV-1 matrix protein p17 induc ...... atory immature cell phenotype.
@ast
HIV-1 matrix protein p17 induc ...... atory immature cell phenotype.
@en
type
label
HIV-1 matrix protein p17 induc ...... atory immature cell phenotype.
@ast
HIV-1 matrix protein p17 induc ...... atory immature cell phenotype.
@en
prefLabel
HIV-1 matrix protein p17 induc ...... atory immature cell phenotype.
@ast
HIV-1 matrix protein p17 induc ...... atory immature cell phenotype.
@en
P2093
P2860
P356
P1476
HIV-1 matrix protein p17 induc ...... atory immature cell phenotype.
@en
P2093
Arnaldo Caruso
Carlos A Guzman
Elena Riboldi
Fabio Facchetti
Giorgio Tosti
Manuela Avolio
Marco Fabbri
Pablo D Becker
Silvano Sozzani
Simona Fiorentini
P2860
P304
P356
10.1073/PNAS.0800370105
P407
P577
2008-02-29T00:00:00Z